construction of pires2 vector encoding truncated ns3 of hcv and il-18 for dna vaccine studies

Authors

m zavvar pasteur institute of iran

a moshiri pasteur institute of iran

f motevali pasteur institute of iran

mh pouriayevali tarbiat modares university

abstract

introduction: long term complications of hepatitis c virus (hcv) infection include fibrosis, cirrhosis, and hepatocellular carcinoma and although the disease is treatable with the newly introduced direct acting antivirals, but factors such as drug resistance, viral genotype and adverse effects can limit the effectiveness of therapy. therefore, development of effective, safe and affordable prophylactic and therapeutic vaccines is a global goal. this study was undertaken for construction of a vector containing the coding region for  a truncated form of nonstructural protein 3 (ns3) of hcv and il-18 cytokine gene fused to murine fcy2a as molecular adjuvantfor assessmentas a dna vaccine candidate.  methods: a truncated form of ns 3 was amplified and cloned in pires2 containing il-18 hybrid gene. expression of the truncated ns3 and bioactivity of il-18 fusion protein were assessed in transfected hek293 t cells. physicochemical properties determination, secondary structure, 3d modelingand t-cell epitope predictionswere made using various online tools. results: in silico analysis of truncated ns3 predicted a molecular weight of 32.35 kda containing epitopic regions with the highest scores for binding to mhc complex. 3d model of il-18showed that fusion with murine fc had not impaired the structure. hek293 t cells were successfully transfected with pires-il18-ns3construct and expression of truncated ns3 with an apparent molecular weight of approximately 32 kda was confirmed by western blotting.  conclusion: despite the advantages, widespread use of dna vaccination has been hampered by low immunogenicity. truncated ns3 was expressed albeit in low amount with bioactive il-18 fusion proteinas a molecular adjuvant immunogenicity assessment of this novel combination as a dna vaccine candidate is underway.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Construction of pIRES2 vector encoding truncated NS3 of HCV and IL-18 for DNA vaccine studies

Introduction: Long term complications of hepatitis C virus (HCV) infection include fibrosis, cirrhosis, and hepatocellular carcinoma and although the disease is treatable with the newly introduced direct acting antivirals, but factors such as drug resistance, viral genotype and adverse effects can limit the effectiveness of therapy. Therefore, development of effective, safe and affordable proph...

full text

construction of pllo vector encoding truncated form of listeriolysin o as molecular adjuvant for dna vaccine studies

background: the major problem of dna vaccine is less immunogenicity of them verses other killed or live whole organism vaccines therefore adjuvants for use in this kind vaccines is very necessary. genetic adjuvants with bacterial sources are an appropriate approach to modulate immune responses to dna vaccines. listeria monocytogenes proteins such as listeriolysin o (llo) with cd4 and cd8 epitop...

full text

Designing and Construction of a Cloning Vector Encoding mtb32C and mpt51 Fragments of Mycobacterium Tuberculosis as a DNA Vaccine Candidate

Background & objective:  Tuberculosis (TB) remains a major cause of death around the world. Bacillus Calmette Guérin (BCG) is the only vaccine used in TB prevention that has a protective effect in children, but its effectiveness declines in adults. Design and development of new vaccines is the most effective way against TB. The aim of this study was to design and construc...

full text

Construction of an Expression Plasmid (Vector) Encoding Brucella melitensis Outer Membrane Protein, a Candidate for DNA Vaccine

Background: DNA vaccination with plasmid encoding bacterial, viral, and parasitic immunogens has been shown to be an attractive method to induce efficient immune responses. Bacteria of the genus Brucella are facultative intracellular pathogens for which new and efficient vaccines are needed. Methods: To evaluate the use of a DNA immunization strategy for protection against brucellosis, a pla...

full text

Designing and construction of a DNA vaccine encoding tb10.4 gene of Mycobacterium tuberculosis

Background: Tuberculosis (TB) remains as a major cause of death around the world. Construction of a new vaccine against tuberculosis is an effective way to control it. Several vaccines against this disease have been developed. The aim of the present study was to cloning of tb10.4 gene in pcDNA3.1+ plasmid and evaluation of its expression in eukaryotic cells. ...

full text

Construction of a Eukaryotic Plasmid Encoding Bacillus anthracis Protective Antigen, a Candidate for DNA Vaccine

Background: DNA immunization with plasmid DNA encoding bacterial, viral, parasitic and tumor antigens has been reported to trigger protective immunity. Objective: To evaluate the use of a DNA immunization strategy for protection against anthrax, a plasmid was constructed. Methods: The partialsequence of protective antigen of Bacillus anthracis, amino acids 175-764, as a potent immunogenic targe...

full text

My Resources

Save resource for easier access later


Journal title:
vaccine research

جلد ۲، شماره ۳، صفحات ۲۴-۲۸

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023